CAPRELSA
Live / Registered — Registered and renewed (as of 15 Aug 2023)
What this means for you
Registered since 18 Sept 2012. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 18 Sept 2022).
Record
- Serial number
- 85360880
- Registration number
- 4211262
- Mark type
- Design + words
- Filed
- 30 Jun 2011
- Published for opposition
- 22 Nov 2011
- Registered
- 18 Sept 2012
- Next maintenance due
- 18 Sept 2022
- Attorney of record
- Karen Lim
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of cancer
Owner
- GENZYME CORPORATION, Cambridge, MA, US
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
Prior registrations
Prosecution history
- 15 Aug 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 15 Aug 2023 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 15 Aug 2023 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 15 Aug 2023 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 20 Jun 2023 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 20 Jun 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Nov 2022 — TEAS SECTION 8 & 9 RECEIVED
- 18 Sept 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 08 Jan 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 10 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Apr 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 Apr 2019 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 03 Apr 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 03 Apr 2019 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 03 Apr 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL